Eli Lilly Trials See Fewer COVID-19 Hospitalizations With Antibody Drug
Indianapolis-based Eli Lilly announced Wednesday its COVID-19 antibody drug is showing results in reducing hospitalizations from the virus. This is the company's first data to be r…
